K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model.
BACKGROUND:K-134 is a more potent antiplatelet drug with a selective inhibitory effect on phosphodiesterase 3 (PDE3) compared with its analogue, cilostazol. OBJECTIVES:This study was performed to compare the ameliorating effects of K-134 and cilostazol on brain damage in an experimental photothrombo...
Main Authors: | Hideo Yoshida, Yuka Ashikawa, Shinsuke Itoh, Takashi Nakagawa, Akimune Asanuma, Sohei Tanabe, Yoshihiro Inoue, Hiroyoshi Hidaka |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3479105?pdf=render |
Similar Items
-
Post-stroke treatment with K-134, a phosphodiesterase 3 inhibitor, improves stroke outcomes in the stroke-prone spontaneously hypertensive rat model–A comparative evaluation of antiplatelet drugs
by: Hideo Yoshida, et al.
Published: (2022-02-01) -
A case of paradoxical cerebral infarction by spraying thrombus in the catheter for dialysis
by: Seiji Hashimoto, et al.
Published: (2017-10-01) -
Correlation of thrombus composition with prognosis of patients with acute cerebral infarction
by: WANG Suxia, et al.
Published: (2019-10-01) -
Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction
by: Xiaoxia Zhao, et al.
Published: (2023-01-01) -
K-134, a phosphodiesterase 3 inhibitor, reduces vascular inflammation and hypoxia, and prevents rupture of experimental abdominal aortic aneurysms
by: Naoki Unno, MD, et al.
Published: (2020-01-01)